Aurobindo Pharma
OverviewSuggest Edit
Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. The company’s product portfolio includes central nervous system, cardiovascular, pain, respiratory, anti-retroviral (for state tenders), metabolic, and anti-infective products. It markets and sells its products to health care professionals.
A well integrated pharma company, Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. Our customers include premium multi-national companies.. With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada and Brazil ANVISA, Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India.
| Type | Public | |
| Founded | 1986 | |
| HQ | Hyderabad, IN | Map |
| Website | aurobindo.com | |
| Employee Ratings | More |
Recent NewsAll News
- Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal
- JPMorgan Makes A Case For Aurobindo Pharma Stock’s Re-Rating
- Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct
- Aurobindo Pharma Q3 Results: Net Profit Jumps Fourfold On One-Offs; Shares Drop
Key People/Management at Aurobindo Pharma
M. Sivakumaran
K. Ragunathan
M. Madan Mohan Reddy
K. Nityananda Reddy
N. Govindarajan
M. Sitarama Murthy
Aurobindo Pharma Office Locations
Aurobindo Pharma Financials and Metrics
Aurobindo Pharma Revenue
Market capitalization (4-Jun-2021) | 561.9b |
Closing stock price (4-Jun-2021) | 959.0 |
Aurobindo Pharma Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Sandoz | September 07, 2018 | $900 m |
Aurobindo Pharma Cybersecurity Score
Aurobindo Pharma Environment, Social & Governance (ESG) Ratings
Aurobindo Pharma Online and Social Media Presence
Aurobindo Pharma's Trends
Aurobindo Pharma News and Updates
Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal
JPMorgan Makes A Case For Aurobindo Pharma Stock’s Re-Rating
Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct
Aurobindo Pharma Q3 Results: Net Profit Jumps Fourfold On One-Offs; Shares Drop
Stocks To Watch: ACC, Aurobindo Pharma, Coal India, Eicher Motors, ITC, Magma Fincorp, Power Grid
Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF
Aurobindo Pharma Frequently Asked Questions
When was Aurobindo Pharma founded?
Aurobindo Pharma was founded in 1986.
Who are Aurobindo Pharma key executives?
Aurobindo Pharma's key executives are M. Sivakumaran, K. Ragunathan and M. Madan Mohan Reddy.
How many employees does Aurobindo Pharma have?
Aurobindo Pharma has 18,469 employees.
Who are Aurobindo Pharma competitors?
Competitors of Aurobindo Pharma include Siegfried Holding, Unither Pharmaceuticals and Merz North America.
Where is Aurobindo Pharma headquarters?
Aurobindo Pharma headquarters is located at Hitech City Rd, Hyderabad.
Where are Aurobindo Pharma offices?
Aurobindo Pharma has offices in Hyderabad and South Brunswick Township.
How many offices does Aurobindo Pharma have?
Aurobindo Pharma has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies